JAMES RIDER: Open Payments
NPI 1215968870 · WINCHESTER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 115 payments from 20 companies in 2025. Trend: 2023 $1,649 · 2024 $1,828 · 2025 $2,336
Food & beverage: $1,898Education: $438
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 10 | $452 |
| E.R. Squibb & Sons, L.L.C. | 13 | $446 |
| Vanda Pharmaceuticals Inc. | 32 | $407 |
| Teva Pharmaceuticals USA, Inc. | 26 | $223 |
| Neurocrine BioSciences, Inc. | 4 | $206 |
| ABBVIE INC. | 5 | $116 |
| Lundbeck LLC | 5 | $103 |
| Viatris Specialty LLC | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
Products named: Kerecis SurgiClose, COBENFY, HETLIOZ, INGREZZA, REXULTI, FANAPT, AUSTEDO XR, TEFLARO.
Industry payments across KS — which companies pay providers there.
